The historical rank and industry rank for Bliss GVS Pharma's OCF Margin % or its related term are showing as below:
BOM:506197'
s OCF Margin % Range Over the Past 10 Years
Min: 4.51 Med: 12.17 Max: 76.74
Current: 14.96
During the past 13 years, the highest OCF Margin % of Bliss GVS Pharma was 76.74%. The lowest was 4.51%. And the median was 12.17%.
BOM:506197's OCF Margin % is ranked better than 65.69% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs BOM:506197: 14.96
Bliss GVS Pharma OCF Margin % Related Terms
Bliss GVS Pharma OCF Margin % Historical Data
* Premium members only.
The historical data trend for Bliss GVS Pharma's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bliss GVS Pharma OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Bliss GVS Pharma's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bliss GVS Pharma (BOM:506197) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bliss GVS Pharma and its competitors. Over the past decade, Bliss GVS Pharma's OCF Margin % has ranged from 4.51 to 76.74. According to the industry distribution chart, Bliss GVS Pharma ranks #329 out of 959 companies in the Drug Manufacturers industry, placing it in the top 34.3%.
Is Bliss GVS Pharma's OCF Margin % too high?
Bliss GVS Pharma's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 4.51 to a high of 76.74. Based on the distribution chart, Bliss GVS Pharma ranks #329 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bliss GVS Pharma has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bliss GVS Pharma's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bliss GVS Pharma ranks #329 out of 959 companies for OCF Margin %. This puts Bliss GVS Pharma in the upper half of its industry. The industry median OCF Margin % is 9.94. Historically, Bliss GVS Pharma's own OCF Margin % has ranged from 4.51 to 76.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bliss GVS Pharma and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bliss GVS Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bliss GVS Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bliss GVS Pharma (BOM:506197) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹152.39, compared to a current price of ₹492.50 — trading 223.2% above its estimated fair value. The current OCF Margin % is 0.00%. Bliss GVS Pharma's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bliss GVS Pharma (BOM:506197), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bliss GVS Pharma (BOM:506197) Overvalued in 2026?
Based on GuruFocus' analysis, Bliss GVS Pharma stock appears to be overvalued.
The current stock price of ₹492.50 is trading 223.2% above its estimated GF Value™ of ₹152.39.
GuruFocus considers Bliss GVS Pharma to be Significantly Overvalued.
Key valuation signals for BOM:506197:
OCF Margin %: 0.00%
GF Value™: ₹152.39 vs. price of ₹492.50 (223.2% above fair value)
No single metric tells the full story. See the BOM:506197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
57GF Score
Get the complete analysis for BOM:506197
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506197 has been successfully added to your 
